As per the study author Dr. Douglas Brand, from The Institute of Cancer Research, “Men would get the same benefit while having to spend less time in hospital”
Studies were conducted on 847 patients split into two groups. One of the groups was administered regular treatment and the other group was treated with SERT for over two weeks. The study revealed, that patients from both the groups had similar side effects after three months of treatment.
This especially goes out for the patients suffering from Prostrate cancer. While is it rough to be diagnosed with a killer like that, a panel of accomplished doctors has worked out a way to reduce a patient’s stay time in the hospital from 3 months to 2 weeks!
The new results from a recent clinical trial showed that shorter courses of high dose radiation do not lead to any short term effect when compared to the current standard of care. If the data collected from the long term side effects come back positive, the trial run can be practice-changing soon enough.
This technique, known as ultra-hypofractionated Stereotactic Body Radiotherapy, is targeted more towards tumors. If the accuracy is precise, it helps in reducing the chance of any tissue damage which can lead to frequent urination and diarrhea.
In the PACE-B study, doctors, and researchers wanted to find out that if it is possible to increase the dose of this target-specific radiation and thus reduce the number of treatments required.
As per Chief Investigator Dr. Nicholas, a clinical oncologist at The Royal Marsden, “At The Royal Marsden and the ICR we are focused on developing smarter, better and kinder treatments for patients across the UK and internationally.”
Indeed, if SERT passes all the short term and long term barriers, it can be very useful in treating tumors more efficiently. It is, in fact, reassuring, that current SERT does not impact the quality of life for patients.
If this works out, dealing with Prostrate cancer will become a lot easier for people around the globe, if not simpler.